Anti-CD7 CAR-T cell Therapy (Shanghai Jiao Tong University Affiliated First People'S Hospital)

N/A

Report date: 2024/08/13 20:00:09

Base Information

Drug NameAnti-CD7 CAR-T cell Therapy (Shanghai Jiao Tong University Affiliated First People'S Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-CD7
TargetsT-cell antigen CD7
Therapy Area/IndicationsAngioimmunoblastic T-cell LymphomaLymphoma, T-Cell, PeripheralLymphoma, Large-Cell, Anaplastic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Jiao Tong University Affiliated First People'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiao Tong University Affiliated First People'S Hospital
Inactive CompaniesN/A
Active IndicationsAngioimmunoblastic T-cell LymphomaLymphoma, T-Cell, PeripheralLymphoma, Large-Cell, Anaplastic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A